SCHEMBL28057781

SCHEMBL28057781

CC(C)(C)C(=O)c1sc(S(=O)(=O)c2ccc(F)cc2)c(N)c1C(N)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 3/20 0.45
IKBKB O14920 4/20 0.43
LMNA P02545 2/20 0.38
HSD11B1 P28845 2/20 0.37
ABCC9 O60706 1/20 0.36
ABCC8 Q09428 1/20 0.36
KCNJ11 Q14654 1/20 0.36
KCNJ8 Q15842 1/20 0.36
F2 P00734 2/20 0.35
PRSS1 P07477 2/20 0.35
PRSS2 P07478 2/20 0.35
PRSS3 P35030 2/20 0.35
MAPT P10636 4/20 0.35
CHUK O15111 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 2/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28057682 0.86 ABCC9 (0.39) CFTRIKBKBABCC9ABCC8KCNJ11
SCHEMBL28156746 0.79 CFTR (0.40) CFTRIKBKBLMNAHSD11B1ABCC9
SCHEMBL28057794 0.69 MEN1 (0.47) CFTRLMNAMAPTKMT2ATHRB
SCHEMBL28156822 0.68 CFTR (0.32) CFTRLMNAMAPTKMT2AKDM4E
SCHEMBL28057649 0.68 LMNA (0.39) LMNAABCC9ABCC8KCNJ11KCNJ8
SCHEMBL28157273 0.67 ABCC9 (0.39) CFTRIKBKBABCC9ABCC8KCNJ11
Potassium SCHEMBL31176741 0.62 HTR2A (0.63) CFTRIKBKBHSD11B1F2PRSS1
SCHEMBL16246531 0.62 ALDH1A1 (0.52) IKBKBLMNAMAPTKMT2AKDM4E
SCHEMBL12289440 0.60 F2 (0.46) CFTRHSD11B1ABCC9ABCC8KCNJ11
SCHEMBL2121770 0.59 HSD11B1 (0.55) LMNAHSD11B1F2PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105531268-A Novel compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis GALAPAGOS NV 2016-04-27 CN disclosed